Thomas Anderson
Vermögen: 231 800 $ am 31.05.2026
Vermögen: 231 800 $ am 31.05.2026
Thomas D.
Anderson is the founder of Tred Avon Advisors LLC, serving as CEO since 2018.
Mr. Anderson is the founder of Zevra Therapeutics, Inc., serving as Independent Director since 2023.
Mr. Anderson is the founder of Robin Hood Ventures, serving as Partner since 2019.
Former positions include President & Chief Executive Officer at Andersen Corp., President & Chief Executive Officer at Ranir, President & CEO at Ranir LLC, Executive Director at Johnson & Johnson from 2003 to 2004, Executive Director-Market Research at Janssen Pharmaceuticals, Inc., Director at ExpressCells, Inc. from 2019 to 2023, Director at SwanBio Therapeutics, Inc. from 2023 to 2024, Director at CEO Trust from 2018 to 2021, Senior Vice President-Corporate Strategy at Shire Plc, Chief Operating Officer & Executive Vice President at Lander Co., Inc., Member at National Association of Corporate Directors (Philadelphia) from 2019 to 2021, Chief Commercial Strategy Officer at SAGE Therapeutics, Inc. from 2014 to 2018, and Advisory Board Member at Sealink International, Inc. from 2019 to 2021.
Education includes an MBA from Mendoza College of Business and an undergraduate degree from Lehigh University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 20’000 ( 0.03% ) | 231 800 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 07.08.2023 |
Robin Hood Ventures
Robin Hood Ventures Investment ManagersFinance RHV invests in companies located in the United States. The firm targets companies operating in the fields of consumer products, information tech, biotechnology, hardtechnology, healthcare and medical devices. It provides financing for seed and early stage capital requirements with an investment size ranging between USD 0.5 - 3 million. It also makes follow on investments and takes a board seat. | Private Equity Investor | 01.03.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops treatments for neurological disorders | Vorstandsvorsitzender | 01.10.2023 |
ExpressCells, Inc.
ExpressCells, Inc. BiotechnologyHealth Technology Engages in creating of custom cell lines for biological research | Direktor/Vorstandsmitglied | 01.01.2023 |
National Association of Corporate Directors (Philadelphia)
National Association of Corporate Directors (Philadelphia) Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides certification, education and event services | Direktor/Vorstandsmitglied | 31.12.2021 |
Tred Avon Advisors LLC | Vorstandsvorsitzender | 31.12.2021 |
Sealink International, Inc.
Sealink International, Inc. AirlinesTransportation Provides air, sea and land freight forwarding and customs clearance services | Berater | 30.09.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 18 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Andersen Corp.
Andersen Corp. Forest ProductsNon-Energy Minerals Manufactures windows and doors | Non-Energy Minerals |
Robin Hood Ventures
Robin Hood Ventures Investment ManagersFinance RHV invests in companies located in the United States. The firm targets companies operating in the fields of consumer products, information tech, biotechnology, hardtechnology, healthcare and medical devices. It provides financing for seed and early stage capital requirements with an investment size ranging between USD 0.5 - 3 million. It also makes follow on investments and takes a board seat. | Finance |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lander Co., Inc.
Lander Co., Inc. Wholesale DistributorsDistribution Services Manufactures and distributes perfumes and cosmetics | Distribution Services |
Ranir/DCP Corp.
Ranir/DCP Corp. Miscellaneous ManufacturingProducer Manufacturing Manufactures consumer oral care products | Producer Manufacturing |
Ranir LLC
Ranir LLC Medical SpecialtiesHealth Technology Manufactures and markets oral care products | Health Technology |
National Association of Corporate Directors (Philadelphia)
National Association of Corporate Directors (Philadelphia) Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides certification, education and event services | Commercial Services |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Mendoza College of Business
Mendoza College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sealink International, Inc.
Sealink International, Inc. AirlinesTransportation Provides air, sea and land freight forwarding and customs clearance services | Transportation |
ExpressCells, Inc.
ExpressCells, Inc. BiotechnologyHealth Technology Engages in creating of custom cell lines for biological research | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops treatments for neurological disorders | Health Technology |
CEO Trust LLC | |
Tred Avon Advisors LLC |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen